Literature DB >> 19694632

Relative vs. absolute measures of benefit and risk: what's the difference?

L Citrome1.   

Abstract

OBJECTIVE: When appraising evidence clinicians are confronted with two types of comparisons: ratios, such as relative risk, and absolute differences, such as number needed to treat (NNT) or number needed to harm (NNH).
METHOD: A review of the definition, calculation and interpretation of relative measures such as relative risk, odds ratio and the hazard ratio, and how they are different from absolute measures such as NNT and NNH.
RESULTS: Relative and absolute measures provide different perspectives. Ratios can be misleading and exaggerate clinical differences, but NNT can appear to trivialize the risk of potentially important adverse events.
CONCLUSION: There is a need to understand both relative and absolute differences in order to make informed decisions.

Mesh:

Year:  2009        PMID: 19694632     DOI: 10.1111/j.1600-0447.2009.01449.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  Quantifying clinical relevance.

Authors:  Leslie Citrome
Journal:  Innov Clin Neurosci       Date:  2014-05

2.  Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis.

Authors:  Dimitrios Papadopoulos; Dimos-Dimitrios D Mitsikostas
Journal:  CNS Drugs       Date:  2018-11       Impact factor: 5.749

3.  Examining absolute risk of AMD in relation to cataract surgery.

Authors:  Kerri P Howard; Barbara E K Klein; Ronald Klein
Journal:  Ophthalmology       Date:  2013-07       Impact factor: 12.079

4.  Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm.

Authors:  Leslie Citrome; Yangchun Du; Peter J Weiden
Journal:  Neuropsychiatr Dis Treat       Date:  2019-09-12       Impact factor: 2.570

Review 5.  Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.

Authors:  Diogo Mendes; Carlos Alves; Francisco Batel-Marques
Journal:  CNS Drugs       Date:  2016-10       Impact factor: 6.497

6.  Dynamic foot function as a risk factor for lower limb overuse injury: a systematic review.

Authors:  Geoffrey J Dowling; George S Murley; Shannon E Munteanu; Melinda M Franettovich Smith; Bradley S Neal; Ian B Griffiths; Christian J Barton; Natalie J Collins
Journal:  J Foot Ankle Res       Date:  2014-12-19       Impact factor: 2.303

Review 7.  Effectiveness of Helicobacter pylori eradication in the prevention of primary gastric cancer in healthy asymptomatic people: A systematic review and meta-analysis comparing risk ratio with risk difference.

Authors:  Takeshi Seta; Yoshimitsu Takahashi; Yoshinori Noguchi; Satoru Shikata; Tatsuya Sakai; Kyoko Sakai; Yukitaka Yamashita; Takeo Nakayama
Journal:  PLoS One       Date:  2017-08-17       Impact factor: 3.240

8.  Number needed to treat (NNT) in clinical literature: an appraisal.

Authors:  Diogo Mendes; Carlos Alves; Francisco Batel-Marques
Journal:  BMC Med       Date:  2017-06-01       Impact factor: 8.775

9.  Gait parameters associated with hallux valgus: a systematic review.

Authors:  Sheree E Nix; Bill T Vicenzino; Natalie J Collins; Michelle D Smith
Journal:  J Foot Ankle Res       Date:  2013-03-12       Impact factor: 2.303

10.  High short-term and long-term excess mortality in geriatric patients after hip fracture: a prospective cohort study in Taiwan.

Authors:  Li-Wei Hung; Wo-Jan Tseng; Guey-Shiun Huang; Jinn Lin
Journal:  BMC Musculoskelet Disord       Date:  2014-05-09       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.